{'output': [['Trump Administration', 'ORG/GOV', 'Impact', 'Deals', 'EVENT'], ['U.S. Companies', 'ORG', 'Operate_In', 'U.S.', 'GPE'], ['U.S. Companies', 'ORG', 'Has', '35 percent', 'ECON_INDICATOR'], ['U.S. Companies', 'ORG', 'Has', '21 percent', 'ECON_INDICATOR'], ['Brent Saunders', 'PERSON', 'Expects', 'Consolidation', 'CONCEPT'], ['Celgene Corp', 'COMP', 'Announce', 'Acquisition', 'EVENT'], ['Large-cap pharmaceutical companies', 'ORG', 'Consolidate', 'Rivals', 'ORG'], ['Bankers', 'PERSON', 'Said', 'Transformative Deals', 'CONCEPT'], ['U.S. Based Acquirer', 'ORG', 'Bought', 'Smaller Firm', 'ORG'], ['Pfizer Inc', 'COMP', 'Proposed', 'Purchase', 'EVENT'], ['Allergan', 'COMP', 'Focused', 'Cost Cutting', 'CONCEPT'], ['Healthcare Industry Bankers', 'PERSON', 'Say', 'Catalyst', 'CONCEPT'], ['Drugmakers', 'ORG', 'Repatriate', 'Billions', 'ECON_INDICATOR'], ['Amgen Inc', 'COMP', 'Announce', 'Plans', 'EVENT'], ['Bristol-Myers', 'COMP', 'Announce', 'Plans', 'EVENT'], ['Larger Companies', 'ORG', 'Benefit', 'Repatriation', 'CONCEPT'], ['Larger Companies', 'ORG', 'Lift', 'Market', 'SECTOR'], ['Horizon Pharma', 'COMP', 'Expects', 'Current Strategy', 'CONCEPT'], ['Drug Industry Deals', 'EVENT', 'Trended', 'Lower', 'ECON_INDICATOR'], ['Thomson Reuters', 'COMP', 'Shows', '52 billion', 'ECON_INDICATOR'], ['Johnson & Johnson', 'COMP', 'CFO', 'Said', 'EVENT'], ['Eli Lilly & Co', 'COMP', 'CEO', 'Said', 'EVENT'], ['Merck', 'COMP', 'CFO', 'Said', 'EVENT'], ['Merck', 'COMP', 'Will', 'Seek', 'EVENT'], ['Merck', 'COMP', 'Improve', 'Flexibility', 'CONCEPT']]}